The global leader in
The leader in
A fintech platform
Treating fine lines
Plant AI-based digital farming productivity platform
Ingestible therapeutic platform
Connected care platform for medical devices
Surgical AR/VR visualization platform
Food ingredients and dietary supplements
We know what it takes, and we bring it to the table
For more than two decades, we’ve backed unique category leaders that emerged from Israel. When partnering, we see it as our mission to make the management teams as successful as possible, supporting them with capital, a broad network of connections, operational knowhow, and 24/7 advice - all based on decades of experience in taking companies from any stage to category leadership.
Udi Angel has been a longtime investor and owner of various multi-billion dollar businesses. His entrepreneurial spirit, vast managerial experience, and personal network continuously contribute to XT Hi-Tech's evolution as a leading investor in Israeli technology companies.
Among other activities, he heads several communal and charitable organizations such as “Variety” Children’s Charity Israel (president), and Ruppin Academic Center (chairman of the Board of Governors).
Ori Angel has been active in the technology investment space for years, investing in various categories at both early and growth stages. As a big believer in “technology-led” disruption, he leads the vision of XT Hi-Tech and its investment strategy direction.
Among his various activities, Ori is the CEO of XT maritime, a ship-owning company with over 120 employees and 2,500 seamen.
Ori holds a BS in Investment, Finance and Risk Management from London’s City University and MBA from University of Chicago’s Graduate School of Business. He graduated with honors from both institutions.
Idan Ofer is a world renowned businessman and an active philanthropist whose group owns multi-billion dollar businesses worldwide. His longtime personal interest in technology and innovation as well as deep insights and global network help to better support XT Hi-Tech’s portfolio companies. Among other activities, his group also holds shares in the Spanish football club Atletico Madrid and the Portuguese team FC Famalicao.
Through his and his wife's family foundation, he is donating to Israeli organizations in the fields of education, health, and welfare. He is a member of the advising committee of the Harvard School of Government.
Tom Lavi Associate
Tom joined XT Hi-Tech as an associate in 2021, taking an integral part in the deal sourcing and supporting the portfolio companies. Prior to joining XT-Hi-Tech Tom led an EdTech SaaS company, taking it from zero to hundreds of thousands of users. Earlier in his career, Tom served as a commander in the IDF’s special forces, where he led complicated operations.
Tom holds an MA in Education Policy Management from the Tel-Aviv University and a BA in Psychology from the Reichman University in Herzeliya, Israel.
Assif Stoffman Managing Director
Assif is a serial entrepreneur at heart, with over twenty years of experience in the software and healthcare industries. After holding various key positions at XT Hi-Tech, including heading its Venture Accelerator for several years where he was instrumental in supporting early stage startups from their very beginning, Assif co-founded, headed, and invested in several startups before rejoining XT Hi-Tech early 2020.
Currently, Assif is an active board member at Avenews-GT, BioT Medical, and Nanopass. Notable previous investments include Checkmarx (acquired by Insight Venture Partners), CmyCasa (acquired by Adobe; NASDAQ: ADBE); MentorWave (acquired by Alphabet; NASDAQ: GOOG); and PainReform (NASDAQ: PRFX). In most of these cases, he joined the company in its earliest stages.
Assif holds an LL.M. (negotiation and dispute resolution program) from Bar-Ilan University and an LL.B and BA in Business Administration from The Interdisciplinary Center.
Yoav Sebba Managing Director
Yoav has been identifying, financing, and growing startup companies for over 20 years. Yoav joined the XT Group after serving as a partner in Yozma Venture Capital, one of Israel's anchor VC funds. Prior to Yozma, Yoav served as a project manager at one of Israel's leading commercial banks.
Yoav is an active board member in select XT Hi-Tech portfolio companies, where he leverages an extensive global network to help them achieve their objectives and build value.
Currently, Yoav is serving on the board of Sofwave (TASE: SOFW), Phytech, Epitomee Medical, Cymbio Digital, Healthy.io, Beyeonics Surgical, and ZIM Integrated Shipping (NYSE: ZIM). Previously, Yoav served on the boards of Cognitens (acquired by Hexagon), Kailight Photonics (acquired by Optium), Painreform (Nasdaq: PRFX), and NextNine (acquired by Honeywell).
Yoav holds an MBA from the Haifa University and BS in Management and Industrial Engineering, cum laude, from the Technion Institute of Technology.
Investing in category leaders
Since the late 90s, we’ve seen waves of innovations, and took an active role in some big successes as well as in painful failures.
However, by carefully implementing our strategy, we managed to be a significant ingredient in the creation of market leaders like Checkmarx, Enzymotec, and Lumenis.
Our track record empowers us to invest in those companies we believe will be the next category leaders – even in categories that are still under construction…
Investing with passion
We invest only in companies where we are as excited about their mission as the management teams - and we are all super excited.
We believe in true partnerships, so before joining we try to learn how we can work together all the way, through highs and lows that are always part of the journey.
We have the deepest appreciation for the sacrifices made to build a company, so we offer management teams all, and only, the support they ask for, thus making sure we do not interfere in running the business. We believe this is key for a healthy, long-term partnership.
We will extend our management teams all the help they need, and we always cherish the sacrifice required to build a company
We believe all these are key for a healthy long-term partnership.
in the press
Epitomee Medical completes $51m IPO on the Tel Aviv Stock Exchange
The offering was made at a pre-money valuation of $200m
Tel Aviv-based Cymbio raises $20m in Series B funding
Draws the backing of ex-Amazon and former Shopify executives
BioT Raises $6.5m in Seed Round to accelerate the connected care revolution
BioT's SaaS platform for digital health IoT is set to transform healthcare
Sofwave™ Medical raises $50m and completes initial public offering
The medical aesthetic company which developed an innovative approach to wrinkle reduction raises $50m
Boston Scientific to buy Lumenis surgical division for $1.1b
Boston Scientific plans leaving Lumenis' surgical activities in Israel and expanding the Yokneam offices into a world...
Fintech startup Avenews-GT announces $3m fund raise from global holding group
Avenews-GT, a digital agricultural trading platform, announced a $3 million Series Seed fund raise...